SLC39A1 and neoplasm: Finally, we integrated three sets of data to figure out significantly perturbed pathways at transcription, protein and metabolism levels and to identify potential downstream molecules for SLC39A1 that may aid in understanding its tumor suppression effects, thereby providing new insights for RCC diagnosis and treatment.